Toll Free: 1-888-928-9744

Stelis Biopharma Pvt Ltd - Product Pipeline Review - 2016

Published: Dec, 2016 | Pages: 25 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Stelis Biopharma Pvt Ltd - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Stelis Biopharma Pvt Ltd - Product Pipeline Review - 2016', provides an overview of the Stelis Biopharma Pvt Ltd's pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Stelis Biopharma Pvt Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Stelis Biopharma Pvt Ltd
- The report provides overview of Stelis Biopharma Pvt Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Stelis Biopharma Pvt Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Stelis Biopharma Pvt Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Stelis Biopharma Pvt Ltd's strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Stelis Biopharma Pvt Ltd
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Stelis Biopharma Pvt Ltd's pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Introduction 4 Global Markets Direct Report Coverage 4 Stelis Biopharma Pvt Ltd Snapshot 5 Stelis Biopharma Pvt Ltd Overview 5 Key Facts 5 Stelis Biopharma Pvt Ltd - Research and Development Overview 6 Key Therapeutic Areas 6 Stelis Biopharma Pvt Ltd - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Stelis Biopharma Pvt Ltd - Pipeline Products Glance 12 Stelis Biopharma Pvt Ltd - Clinical Stage Pipeline Products 12 Phase I Products/Combination Treatment Modalities 12 Stelis Biopharma Pvt Ltd - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Stelis Biopharma Pvt Ltd - Drug Profiles 14 SBL-005 - Drug Profile 14 Product Description 14 Mechanism Of Action 14 R&D Progress 14 SBL-011 - Drug Profile 15 Product Description 15 Mechanism Of Action 15 R&D Progress 15 SBL-012 - Drug Profile 16 Product Description 16 Mechanism Of Action 16 R&D Progress 16 teriparatide biosimilar - Drug Profile 17 Product Description 17 Mechanism Of Action 17 R&D Progress 17 Stelis Biopharma Pvt Ltd - Pipeline Analysis 18 Stelis Biopharma Pvt Ltd - Pipeline Products by Target 18 Stelis Biopharma Pvt Ltd - Pipeline Products by Route of Administration 19 Stelis Biopharma Pvt Ltd - Pipeline Products by Molecule Type 20 Stelis Biopharma Pvt Ltd - Pipeline Products by Mechanism of Action 21 Stelis Biopharma Pvt Ltd - Dormant Projects 22 Stelis Biopharma Pvt Ltd - Locations And Subsidiaries 23 Head Office 23 Other Locations & Subsidiaries 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 24 Disclaimer 25
List of Tables
Stelis Biopharma Pvt Ltd, Key Facts 5 Stelis Biopharma Pvt Ltd - Pipeline by Indication, 2016 7 Stelis Biopharma Pvt Ltd - Pipeline by Stage of Development, 2016 8 Stelis Biopharma Pvt Ltd - Monotherapy Products in Pipeline, 2016 9 Stelis Biopharma Pvt Ltd - Partnered Products in Pipeline, 2016 10 Stelis Biopharma Pvt Ltd - Partnered Products/ Combination Treatment Modalities, 2016 11 Stelis Biopharma Pvt Ltd - Phase I, 2016 12 Stelis Biopharma Pvt Ltd - Preclinical, 2016 13 Stelis Biopharma Pvt Ltd - Pipeline by Target, 2016 18 Stelis Biopharma Pvt Ltd - Pipeline by Route of Administration, 2016 19 Stelis Biopharma Pvt Ltd - Pipeline by Molecule Type, 2016 20 Stelis Biopharma Pvt Ltd - Pipeline Products by Mechanism of Action, 2016 21 Stelis Biopharma Pvt Ltd - Dormant Developmental Projects,2016 22 Stelis Biopharma Pvt Ltd, Subsidiaries 23



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify